AutoZone delivered its fiscal Q3 results on May 26 and the market's verdict was swift: the stock dropped 9% the next day to $3,100, extending a monthly decline that now stands at 13%.
The analyst response has been immediate and uniform. Every firm that moved on the number this morning cut its price target — but not a single one changed its rating. JPMorgan kept Overweight while trimming to $3,850 from $4,300. Morgan Stanley held Overweight and pulled its target to $3,605 from $4,020. Guggenheim, BMO Capital, and Baird all maintained positive or neutral ratings while lowering numbers by $300-$500. The message from the Street is consistent: the quarter disappointed on margins, but the thesis is intact. The consensus mean target has settled around $3,931, roughly 27% above current levels. Bulls point to an FY27 EPS estimate of $186 and expected margin recovery as the structural case. Bears flag LIFO charges, margin compression, and a store growth pace that may not offset rising costs. With 17 buys and 3 outperforms in the consensus, the ratings skew is firmly constructive — yet the target resets signal the Street is recalibrating its timeline.
Short positioning tells a calmer story than the price action implies. At 2.1% of the free float, short interest remains low in absolute terms, nudging up just under 2% on the week to around 351,000 shares. That continues the gentle drift higher from the late-April build — but this is accumulation, not aggression. The borrow market offers no stress signals to speak of: cost to borrow has actually eased to 0.34% from 0.50% a week ago, and availability remains extraordinarily loose at over 6,700%. There are approximately 67 shares available to borrow for every one currently lent out. That is far from the tightest point of the past year. Shorts are present, but there is nothing in the lending market to suggest a squeeze is building.
Options positioning has barely flinched. The put/call ratio came in at 0.70, almost exactly in line with its 20-day average of 0.69 and a z-score near zero. There is no defensive scramble in the options market following the earnings drop — no spike in put demand, no sign of panic hedging. The PCR has actually drifted lower from the mid-May peak near 0.77, suggesting call interest held relatively firm even through the sell-off. That calm sits in contrast to a stock down 13% over the past month. The closest peer, ORLY, fell 2% on the day versus AZO's 9%, while TSCO dropped nearly 6% on the week — so some of the pressure is sector-wide, though AZO bore the brunt.
The PE multiple has compressed to around 19.4x, down more than 3 points over the past month, while EV/EBITDA has contracted to 13.9x — a notable reset from where it started May. The EPS momentum scores remain constructive at the mid-50s percentile, and the 12-month forward EPS increase measure ranks in the 74th percentile, suggesting the forward earnings picture has not fundamentally deteriorated. Factor scores on DTC and short interest rank modestly elevated at the 70th and 68th percentiles respectively, consistent with a stock where positioning is more active than usual — but not extreme.
What to watch next is the fiscal Q4 setup. The next event is confirmed for June 2 at 4:30pm ET — a short fuse from here. The last comparable earnings print in March produced a 3% one-day drop and a 10% five-day slide, a reminder that post-earnings drift has been the sharper pain trade for AZO in recent quarters. With targets reset, ratings held, and positioning still relaxed, the June print becomes a test of whether the margin recovery story the bulls are counting on starts to show up in the numbers.
See the live data behind this article on ORTEX.
Open AZO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
